A prehabilitation programme implemented before robot-assisted radical prostatectomy improves peri-operative outcomes and continence recovery.


Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
09 2022
Historique:
pubmed: 3 12 2021
medline: 26 8 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

To assess the impact of a routine, on-site, 1-day prehabilitation (PreHab) programme on peri-operative and continence recovery after robot-assisted radical prostatectomy (RARP). All 303 consecutive RARPs performed between March 2018 and February 2020 since the routine implementation of PreHab were included in our study. PreHab was carried out according to the availability of the 1-day programme before the planned date of surgery (two sessions per month including four patients per session). The PreHab programme was implemented in 165 patients (54.5%). The primary endpoint was continence recovery, strictly defined as no safety pad use at 1 and 6 months. Secondary endpoints were peri-operative variables (blood loss, operating time, length of stay, transfusion, complications, and readmission rates). Comparisons were made according to whether the PreHab pathway was applied or not (PreHab+ vs PreHab-) in univariable and multivariable models. The PreHab pathway was implemented for a stable proportion of patients over time (54.5%). The two cohorts were comparable in terms of preoperative and pathological features (P > 0.05). Length of stay was significantly shorter in the PreHab+ group (1.3 vs 1.9 days; P = 0.001). There was a trend towards fewer complications in the PreHab+ group (P = 0.061). Use of the PreHab pathway was independently correlated with higher continence rates at 1 month (37% vs 60%; P < 0.001) and 6 months (67.4% vs 87.3%; P < 0.001), even after controlling for age, body mass index, prostate volume, type of apical reconstruction, nerve-sparing surgery and lymph node dissection. The main limitation of the study was the absence of randomization. Our experience demonstrates that the PreHab programme is the major predictor of improved peri-operative outcomes and continence recovery after RARP, with sustainable benefits 6 months after surgery.

Identifiants

pubmed: 34854212
doi: 10.1111/bju.15666
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

357-363

Informations de copyright

© 2021 The Authors BJU International © 2021 BJU International.

Références

Mottet N, van den Bergh RCN, Briers E et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 2021; 79: 243-62
Ploussard G. Robotic surgery in urology: facts and reality. What are the real advantages of robotic approaches for prostate cancer patients? Curr Opin Urol 2018; 28: 153-8
Coughlin GD, Yaxley JW, Chambers SK et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study. Lancet Oncol 2018; 19: 1051-60
Rosenberg JE, Jung JH, Edgerton Z et al. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer. Cochrane Database Syst Rev 2020; (8): CD013641
Martini A, Falagario UG, Villers A et al. Contemporary techniques of prostate dissection for robot-assisted prostatectomy. Eur Urol 2020; 78: 583-91
Qiu X, Li Y, Chen M et al. Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up. BJU Int 2020; 126: 633-40
Menon M, Dalela D, Jamil M et al. Functional recovery, oncologic outcomes and postoperative complications after robot-assisted radical prostatectomy: an evidence-based analysis comparing the Retzius sparing and standard approaches. J Urol 2018; 199: 1210-7
Azhar RA, Bochner B, Catto J et al. Enhanced recovery after urological surgery: a contemporary systematic review of outcomes, key elements, and research needs. Eur Urol 2016; 70: 176-87
Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg 2002; 183: 630-41
Singh F, Newton RU, Galvão DA, Spry N, Baker MK. A systematic review of pre-surgical exercise intervention studies with cancer patients. Surg Oncol 2013; 22: 13
Tang CY, Turczyniak M, Sayner A, Haines K, Butzkueven S, O'Connell HE. Adopting a collaborative approach in developing a prehabilitation program for patients with prostate cancer utilising experience-based co-design methodology. Support Care Cancer 2020; 28: 5195-202
Santa Mina D, Hilton WJ, Matthew AG et al. Prehabilitation for radical prostatectomy: a multicentre randomized controlled trial. Surg Oncol 2018; 27: 289-98
Minnella EM, Awasthi R, Bousquet-Dion G et al. Multimodal prehabilitation to enhance functional capacity following radical cystectomy: a randomized controlled trial. Eur Urol Focus 2019:S2405-4569
Ploussard G, Almeras C, Beauval J-B et al. A combination of enhanced recovery after surgery and prehabilitation pathways improves perioperative outcomes and costs for robotic radical prostatectomy. Cancer 2020; 126: 4148-55
Ploussard G, Loison G, Almeras C et al. One-day prehabilitation program before robotic radical prostatectomy in daily practice: routine feasibility and benefits for patients and hospitals. Eur Urol Open Sci 2020; 21: 14-6
Minnella EM, Carli F, Kassouf W. Role of prehabilitation following major uro-oncologic surgery: a narrative review. World J Urol 2020. https://doi.org/10.1007/s00345-020-03505-4
Paterson C, Primeau C, Pullar I, Nabi G. Development of a prehabilitation multimodal supportive care interventions for men and their partners before radical prostatectomy for localized prostate cancer. Cancer Nurs 2019; 42: E47-53
Reynolds BR, Bulsara C, Zeps N et al. Exploring pathways towards improving patient experience of robot-assisted radical prostatectomy (RARP): assessing patient satisfaction and attitudes. BJU Int 2018; 121: 33-9
Mitropoulos D, Artibani W, Biyani CS, Bjerggaard Jensen J, Rouprêt M, Truss M. Validation of the Clavien-Dindo grading system in urology by the European association of urology guidelines ad hoc panel. Eur Urol Focus 2018; 4: 608-13
Rath HM, Ullrich A, Otto U et al. Psychosocial and physical outcomes of in- and outpatient rehabilitation in prostate cancer patients treated with radical prostatectomy. Support Care Cancer 2016; 24: 2717-26
Jayadevappa R, Chhatre S, Gallo JJ et al. Patient-centered preference assessment to improve satisfaction with care among patients with localized prostate cancer: a randomized controlled trial. J Clin Oncol 2019; 37: 964-73
Tsimopoulou I, Pasquali S, Howard R et al. Psychological prehabilitation before cancer surgery: a systematic review. Ann Surg Oncol 2015; 22: 4117-23
Pang KH, Groves R, Venugopal S, Noon AP, Catto JWF. Prospective implementation of enhanced recovery after surgery protocols to radical cystectomy. Eur Urol 2018; 73: 363-71
Ploussard G, Almeras C, Beauval JB et al. Same-day discharge surgery for robot-assisted radical prostatectomy in the era of ERAS and prehabilitation pathways: a contemporary, comparative, feasibility study. World J Urol 2020. https://doi.org/10.1007/s00345-020-03119
Abaza R, Martinez O, Ferroni MC, Bsatee A, Gerhard RS. Same day discharge after robotic radical prostatectomy. J Urol 2019; 202: 959-63
Rahota RG, Salin A, Gautier JR et al. Same day discharge versus inpatient surgery for robot-assisted radical prostatectomy: a comparative study. J Clin Med 2021; 10: 661. Published 2021 Feb 9
Ploussard G, Grabia A, Beauval J-B et al. Impact of hospital volume on postoperative outcomes after radical prostatectomy: a 5-year nationwide database analysis [published online ahead of print, 2021 Jun 16]. Eur Urol Focus 2021. https://doi.org/10.1016/j.euf.2021.06.005

Auteurs

Razvan-George Rahota (RG)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Ambroise Salin (A)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Jean-Romain Gautier (JR)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Christophe Almeras (C)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Valérie Garnault (V)

Public Health Department, PMSI, La Croix du Sud Hospital, Quint Fonsegrives, France.

Christophe Tollon (C)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Guillaume Loison (G)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Jean-Baptiste Beauval (JB)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Guillaume Ploussard (G)

Urology Department, La Croix du Sud Hospital, Quint Fonsegrives, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH